Indicators
Indicators
Value
Direction
MACD(12,26,9)
-4.876
Neutral
RSI(14)
48.630
Neutral
STOCH(KDJ)(9,3,3)
20.216
Neutral
ATR(14)
5.496
High Vlolatility
CCI(14)
-116.465
Sell
Williams %R
71.011
Sell
TRIX(12,20)
0.411
Sell
StochRSI(14)
66.480
Buy
Search
Abivax SA
ABVXAdd to Watchlist
124.810USD
+0.480+0.39%
Close 07-30 16:00（ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
+0.39%
5 Days
-4.84%
1 Month
-6.34%
6 Months
+12.29%
Year to Date
-7.45%
1 Year
+76.20%
Key Figures
127.260Open
127.510High
1.24MVolume
--P/E TTM
0.00P/E Dynamic
--Dividend TTM
--Turnover Ratio
124.330Prev. Close
120.620Low
82.13MTurnover
--P/E Static
--P/B
0.00%Div Yield TTM
--ROA
148.83052wk High
1.17Volume Ratio
--Net Profit
--Shares
--EPS TTM
--Beta
--ROE
5.69052wk Low
5.54%Amplitude
--Gross Margin
0.00Market Cap
-4.50Reward/Risk
3.12%Risk Rate
Abivax SA News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
12
analysts
Buy
Current Rating
156.154
Target Price
+31.40%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
496
Total
6
Median
7
Average
Company name
Ratings
Analysts
Abivax SA
ABVX
12
Beigene Ltd
ONC
27
argenx SE
ARGX
26
IQVIA Holdings Inc
IQV
26
Ionis Pharmaceuticals Inc
IONS
25
Insmed Inc
INSM
23
1
2
3
...
99
Indicators
Moving Average
Indicators
Value
Direction
MA5
124.220
Buy
MA10
128.423
Sell
MA20
133.991
Sell
MA50
118.315
Buy
MA100
117.768
Buy
MA200
116.688
Buy
Abivax SA Info
Abivax SA is a clinical stage biopharmaceutical company focusing on the discovery, development and commercialization of anti-viral compounds and therapeutic vaccines against severe and life threatening infectious diseases. ABIVAX utilizes RNA-protein interaction interference and cytotoxic TH1 cell amplification to generate therapies to help patients clear viruses like HIV, HBV and HPV. The Company's product pipeline comprises ABX 203, which is the therapeutic vaccine candidate obtained from the Centre for Genetic Engineering and Biotechnology, Cuba (CIGB) and is intended for patients with chronic hepatitis B disease; and ABX196, the adjuvant for therapeutic vaccines, among others.
Ticker SymbolABVX
CompanyAbivax SA
CEOde Garidel (Marc)
Websitehttps://www.abivax.com/
Shareholders
Popular Instruments
52378.000
+109.000 (+0.21%)
28160.900
-37.600 (-0.13%)
7475.100
+30.800 (+0.41%)
14749.000
-90.000 (-0.61%)
62852.000
-742.000 (-1.17%)
6365.400
-1.000 (-0.02%)
85.934
+2.764 (+3.32%)
308.640
-24.790 (-7.43%)
200.760
+5.720 (+2.93%)
4041.430
-61.400 (-1.50%)
FAQs
What is the current price of Abivax SA (ABVX)?
The current price of Abivax SA (ABVX) is 124.32.
What is the symbol of Abivax SA?
The ticker symbol of Abivax SA is ABVX.
What is the 52-week high of Abivax SA?
The 52-week high of Abivax SA is 148.83.
What is the 52-week low of Abivax SA?
The 52-week low of Abivax SA is 5.69.
Is Abivax SA (ABVX) currently rated as Buy, Hold, or Sell?
According to analysts, Abivax SA (ABVX) has an overall rating of Buy, with a price target of 156.15.